Archive for the ‘News’ category

Pushing Western medicine with fear in India

July 8th, 2011

f you sleep less than six hours a night, you’re increasing your risk of developing or dying from heart disease by 48 percent. At least, that’s what U.S.-based pharmaceutical giant Abbott would have 1.2 billion people in India believe.

But doctors say the grim message, which appeared in a newspaper ad in India earlier this year, is baseless. In fact, they worry Abbott’s marketing campaign may be the bigger threat, scaring healthy people into buying potentially harmful sleeping pills they don’t need — such as the company’s own drug Zolfresh.

“They are implying that taking sleeping pills may help you live longer, whereas the data shows that taking sleeping pills is associated with increased mortality,” said Dr. Daniel F. Kripke, a psychiatrist at the University of California, San Diego.
» Read more: Pushing Western medicine with fear in India

Colon cancer deaths down except in Mississippi

July 6th, 2011

Colon cancer deaths continue to drop across America — except in Mississippi, health officials said Tuesday. The Centers for Disease Control and Prevention issued a report that echoes earlier findings of a national decline in colon cancer deaths. Rates fell by as much as 5 and 6 percent in a few states — Massachusetts, Connecticut and Rhode Island.

Mississippi was the only state that saw no real decline, according to the CDC report. “The big picture is screenings are up, death rates are down, and even more progress is possible,” said the CDC’s director, Dr. Thomas Frieden.
» Read more: Colon cancer deaths down except in Mississippi

Medicare confirms payment for prostate cancer drug

July 1st, 2011

Medicare officials confirmed Thursday that the program will cover the $93,000 price tag for prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the disease an extra four months to live.

The decision from the Centers for Medicare and Medicaid essentially reiterates an earlier proposed ruling that the biotech drug, made by Dendreon Corp., is a “reasonable and necessary” medicine. As expected, the government will cover the cost for men who meet the drug’s approved criteria: those with prostate disease that has spread throughout the body and has not responded to hormone therapy or radiation. The government will not pay for alternate, or so called “off-label,” use.
» Read more: Medicare confirms payment for prostate cancer drug

Lifestyle Changes Might Alter Breast Cancer Rates

June 25th, 2011

Lifestyle changes such as losing weight, drinking less alcohol and getting more exercise could lead to a substantial reduction in breast cancer cases across an entire population, according to a new model that estimates the impact of these modifiable risk factors.

Although such models are often used to estimate breast cancer risk, they are usually based on things that women can’t change, such as a family history of breast cancer. Up to now, there have been few models based on ways women could reduce their risk through changes in their lifestyle.
» Read more: Lifestyle Changes Might Alter Breast Cancer Rates

Docs overtesting for cervical cancer virus

June 21st, 2011

Too many doctors are testing the wrong women, or using the wrong test, for a virus that causes cervical cancer. The days of one-size-fits-all screening for cervical cancer are long gone. How often to get a Pap smear — and whether to be tested for the cancer-causing HPV virus at the same time — now depend on your age and other circumstances.

But a government study reports Monday that a surprising number of doctors and clinics aren’t following guidelines from major medical groups on how to perform HPV checks, suggesting a lot of women are getting unnecessary tests. That wastes money and could harm women who wind up getting extra medical care they didn’t need, says Dr. Mona Saraiya of the Centers for Disease Control and Prevention, who led the research.
» Read more: Docs overtesting for cervical cancer virus

Cancer death rate gap widens based on education

June 17th, 2011

The gap in cancer death rates between college graduates and those who only went to high school is widening, the American Cancer Society reported Friday. Among men, the least educated died of cancer at rates more than 2 1/2 times that of men with college degrees, the latest data show. In the early 1990s, they died at two times the rate of most-educated men.

For women, the numbers aren’t as complete but suggest a widening gap also. The data, from 2007, compared people between the ages of 25 and 64. People with college degrees are seeing a significant drop in cancer death rates, while people who have spent less time in school are seeing more modest improvements or sometimes none at all, explained Elizabeth Ward, who oversees research done by the cancer society.
» Read more: Cancer death rate gap widens based on education

Prostate drugs raise risk of prostate cancer

June 9th, 2011

A class of drugs meant to improve symptoms of an enlarged prostate gland actually increase the chance of getting a more serious form of prostate cancer, health officials said on Thursday. However, they also said the drugs’ benefits outweigh the risks.

The drugs in this group include Merck & Co’s Proscar and GlaxoSmithKline’s Avodar and Jalyn, as well as Merck’s Propecia, which is approved to treat male pattern hair loss. The Food and Drug Administration said it revised the labels on all such drugs, called 5-alpha reductase inhibitors (5-ARI), to include the risk after reviewing two large studies.
» Read more: Prostate drugs raise risk of prostate cancer

Antidepressant may not cut hot flashes after all

May 31st, 2011

New research throws a wet blanket on an earlier study that showed women in menopause might get dramatic relief from hot flashes by taking the antidepressant Lexapro. According to the new findings, Forest Laboratories’ Lexapro, also called escitalopram, reduces neither the severity nor frequency of hot flashes associated with menopause. Robert Freedman, a behavioral scientist at Wayne State University in Detroit who led the work, says he was “disappointed” by the results.

“We wouldn’t have done the study if we had not expected an effect” from the drug, Freedman told Reuters Health.Roughly 75 percent of women in menopause experience hot flashes, and nearly half of them report severe episodes. Hormone replacement therapy has long been the standard treatment for the bothersome symptoms, but millions of women stopped using the drugs after it became clear that they increase the risk of cancer and heart disease.
» Read more: Antidepressant may not cut hot flashes after all

Complexities of Autism Extend to Its Treatment

May 28th, 2011

Parents of children with autism often find themselves struggling to make sense of their child’s behavior. What’s worse, there’s no single best way to treat the frightening and frustrating neurodevelopmental disorder. Children might have a mix of social impairments, communication problems and repetitive behavior patterns. Each child will require a certain blend of therapies, treatments and interventions, all specifically tailored to the child’s particular behavioral problems.

“Every person with autism is different,” said Lee Grossman, president and chief executive of the Autism Society. “There’s a saying, ‘If you’ve met one person with autism, then you’ve met one person with autism.’” That means parents usually have to figure it out for themselves, with help from their medical team. Experts agree on two basic principles when it comes to treating people with autism, according to the U.S. National Institute of Mental Health:
» Read more: Complexities of Autism Extend to Its Treatment

UN puts off destroying last smallpox viruses

May 26th, 2011

Health ministers from around the world agreed Tuesday to put off setting a deadline to destroy the last known stockpiles of the smallpox virus for three more years, rejecting a U.S. plan that had called for a five-year delay. After two days of heated debate, the 193-nation World Health Assembly agreed by consensus to a compromise that calls for another review in 2014.

The United States had proposed a five-year extension to destroying the U.S. and Russian stockpiles, arguing that more research is needed and the stockpiles could help prevent one of the world’s deadliest diseases from being used as a biological weapon.
» Read more: UN puts off destroying last smallpox viruses